ASKA Pharmaceutical Holdings Co Ltd
TSE:4886

Watchlist Manager
ASKA Pharmaceutical Holdings Co Ltd Logo
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
Watchlist
Price: 2 050 JPY 0.69% Market Closed
Market Cap: 58.1B JPY
Have any thoughts about
ASKA Pharmaceutical Holdings Co Ltd?
Write Note

ASKA Pharmaceutical Holdings Co Ltd
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ASKA Pharmaceutical Holdings Co Ltd
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
Research & Development
-ÂĄ4.7B
CAGR 3-Years
N/A
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
Research & Development
-ÂĄ727.3B
CAGR 3-Years
-26%
CAGR 5-Years
-10%
CAGR 10-Years
-8%
Daiichi Sankyo Co Ltd
TSE:4568
Research & Development
-ÂĄ392.4B
CAGR 3-Years
-19%
CAGR 5-Years
-15%
CAGR 10-Years
-34%
Otsuka Holdings Co Ltd
TSE:4578
Research & Development
-ÂĄ312.3B
CAGR 3-Years
-24%
CAGR 5-Years
-6%
CAGR 10-Years
-2%
Chugai Pharmaceutical Co Ltd
TSE:4519
Research & Development
-ÂĄ171B
CAGR 3-Years
-19%
CAGR 5-Years
-10%
CAGR 10-Years
-9%
Astellas Pharma Inc
TSE:4503
Research & Development
-ÂĄ324.6B
CAGR 3-Years
-12%
CAGR 5-Years
-9%
CAGR 10-Years
-5%
No Stocks Found

ASKA Pharmaceutical Holdings Co Ltd
Glance View

Market Cap
58.1B JPY
Industry
Pharmaceuticals

ASKA Pharmaceutical Holdings Co., Ltd. engages in the management of its group companies which are involved in the manufacture and sale of pharmaceuticals, quasi-drugs, food, veterinary drugs, feeds, feed additives, and medical devices. The company is headquartered in Minato-Ku, Tokyo-To. The company went IPO on 2021-04-01. The firm mainly operates in two business segments. The Pharmaceutical segment is mainly engaged in the manufacture, purchase and sale of pharmaceutical products. The Others segment is involved in the manufacture of veterinary drugs, the provision of clinical testing services, the outsourcing of testing services, the purchase and sale of medical equipment, as well as the sale of health foods.

Intrinsic Value
3 410.94 JPY
Undervaluation 40%
Intrinsic Value
Price

See Also

What is ASKA Pharmaceutical Holdings Co Ltd's Research & Development?
Research & Development
-4.7B JPY

Based on the financial report for Mar 31, 2024, ASKA Pharmaceutical Holdings Co Ltd's Research & Development amounts to -4.7B JPY.

What is ASKA Pharmaceutical Holdings Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-1%

Over the last year, the Research & Development growth was -12%.

Back to Top